A nurse is caring for a client who is having difficulty remembering to take their prescribed drug

1. Sabaté E, ed. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003. [Google Scholar]

2. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-2571 [PubMed] [Google Scholar]

3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497 [PubMed] [Google Scholar]

4. Huth EJ, Murray TJ, eds. Medicine in Quotations: Views of Health and Disease Through the Ages. 2nd ed. Philadelphia, PA: American College of Physicians; 2006. [Google Scholar]

5. Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132(11):926-930 [PubMed] [Google Scholar]

6. Winkler A, Teuscher AU, Mueller B, Diem P. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly. 2002;132(27-28):379-385 [PubMed] [Google Scholar]

7. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913 [PubMed] [Google Scholar]

8. Smith SC, Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363-2372 [PubMed] [Google Scholar]

9. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet NeUrol. 2009;8(5):453-463 [PubMed] [Google Scholar]

10. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-1278 [PubMed] [Google Scholar]

11. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684577/ Published May 19, 2009. Accessed November 12, 2009 [PMC free article] [PubMed] [Google Scholar]

12. Glader EL, Sjölander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41(2):397-401 [PubMed] [Google Scholar]

13. Costa FV. Compliance with antihypertensive treatment. Clin Exp Hypertens. 1996;18(3-4):463-472 [PubMed] [Google Scholar]

14. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1):76-87 [PMC free article] [PubMed] [Google Scholar]

15. Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens (Greenwich). 2008;10(1, suppl 1):20-26 [PMC free article] [PubMed] [Google Scholar]

16. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772-779 [PubMed] [Google Scholar]

17. Kettani FZ, Dragomir A, Cote R, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009;40(1):213-220 [PubMed] [Google Scholar]

18. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598-1605 [PubMed] [Google Scholar]

19. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39(5):1647-1652 [PMC free article] [PubMed] [Google Scholar]

20. Kushner FG, Hand M, Smith SC, Jr, et al. 2009 Focused Updates: ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on percutaneous coronary intervention (Updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120(22):2271-2306 [PubMed] [Google Scholar]

21. Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther. 2007;21(4):311-316 [PubMed] [Google Scholar]

22. Deambrosis P, Saramin C, Terrazzani G, et al. Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003. Eur J Clin Pharmacol. 2007;63(2):197-203 [PubMed] [Google Scholar]

23. Perreault S, Dragomir A, Blais L, et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009;65(10):1013-1024 [PubMed] [Google Scholar]

24. Poluzzi E, Strahinja P, Lanzoni M, et al. Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy. Eur J Clin Pharmacol. 2008;64(4):425-432 [PubMed] [Google Scholar]

25. Chodick G, Shalev V, Gerber Y, et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin Ther. 2008;30(11):2167-2179 [PubMed] [Google Scholar]

26. Evans CD, Eurich DT, Lamb DA, et al. Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada. J Manag Care Pharm. 2009;15(6):476-484 [PubMed] [Google Scholar]

27. National Cholesterol Education Program (NCEP) Expert Panel Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421 [PubMed] [Google Scholar]

28. Waters DD, Brotons C, Chiang CW, et al. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation. 2009;120(1):28-34 [PubMed] [Google Scholar]

29. Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long-term adherence with cardiovascular drug regimens. Am Heart J. 2006;151(1):185-191 [PubMed] [Google Scholar]

30. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113(2):203-212 [PubMed] [Google Scholar]

31. Hamann GF, Weimar C, Glahn J, Busse O, Diener HC. Adherence to secondary stroke prevention strategies: results from the German Stroke Data Bank. Cerebrovasc Dis. 2003;15(4):282-288 [PubMed] [Google Scholar]

32. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842-1847 [PubMed] [Google Scholar]

33. Melloni C, Alexander KP, Ou FS, et al. Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol. 2009;104(2):175-181 [PubMed] [Google Scholar]

34. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113(24):2803-2809 [PubMed] [Google Scholar]

35. Pallares MJ, Powers ER, Zwerner PL, Fowler A, Reeves R, Nappi JM. Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann PharmacoTher. 2009;43(2):259-267 [PubMed] [Google Scholar]

36. Roy P, Bonello L, Torguson R, et al. Temporal relation between clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009;103(6):801-805 [PubMed] [Google Scholar]

37. Lesaffre E, Kocmanova D, Lemos PA, Disco CM, Serruys PW. A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS. Clin Ther. 2003;25(9):2431-2447 [PubMed] [Google Scholar]

38. Perreault S, Ellia L, Dragomir A, et al. Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med. 2009;122(7):647-655 [PubMed] [Google Scholar]

39. Dragomir A, Côté R, White M, et al. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value Health. 2010;13(1):87-94 [PubMed] [Google Scholar]

40. Wiederkehr D, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Corbelli J. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population. Curr Med Res Opin. 2009;25(9):2327-2334 [PubMed] [Google Scholar]

41. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27(22):2667-2674 [PubMed] [Google Scholar]

42. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297(2):159-168 [PubMed] [Google Scholar]

43. Airoldi F, Colombo A, Morici N, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007;116(7):745-754 [PubMed] [Google Scholar]

44. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126-2130 [PubMed] [Google Scholar]

45. van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009;53(16):1399-1409 [PubMed] [Google Scholar]

46. Ryan AA. Medication compliance and older people: a review of the literature. Int J Nurs Stud. 1999;36(2):153-162 [PubMed] [Google Scholar]

47. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880-2883 [PubMed] [Google Scholar]

48. Raynor DK. Medication literacy is a 2-way street [editorial]. Mayo Clin Proc. 2008;83(5):520-522 [PubMed] [Google Scholar]

49. Kindig D, Affonso D, Chudler E, et al. Health Literacy: a Prescription to End Confusion. Washington, DC: Institute of Medicine of the National Academies; 2004. [Google Scholar]

50. Baker DW, Parker RM, Williams MV, Clark WS. Health literacy and the risk of hospital admission. J Gen Intern Med. 1998;13(12):791-798 [PMC free article] [PubMed] [Google Scholar]

51. Mancuso CA, Rincon M. Impact of health literacy on longitudinal asthma outcomes. J Gen Intern Med. 2006;21(8):813-817 [PMC free article] [PubMed] [Google Scholar]

52. Brunner R, Dunbar-Jacob J, Leboff MS, et al. Predictors of adherence in the Women's Health Initiative Calcium and Vitamin D Trial. Behav Med. 2009;34(4):145-155 [PMC free article] [PubMed] [Google Scholar]

53. Joyner-Grantham J, Mount DL, McCorkle OD, Simmons DR, Ferrario CM, Cline DM. Self-reported influences of hopelessness, health literacy, life-style action, and patient inertia on blood pressure control in a hypertensive emergency department population. Am J Med Sci. 2009;338(5):368-372 [PubMed] [Google Scholar]

54. Reach G. Is there an impatience genotype leading to non-adherence to long-term therapies? Diabetologia. 2010;53(8):1562-1567 [PubMed] [Google Scholar]

55. Kripalani S, Henderson LE, Jacobson TA, Vaccarino V. Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc. 2008;83(5):529-535 [PubMed] [Google Scholar]

56. Molloy GJ, Perkins-Porras L, Bhattacharyya MR, Strike PC, Steptoe A. Practical support predicts medication adherence and attendance at cardiac rehabilitation following acute coronary syndrome. J Psychosom Res. 2008;65(6):581-586 [PubMed] [Google Scholar]

57. Molloy GJ, Perkins-Porras L, Strike PC, Steptoe A. Social networks and partner stress as predictors of adherence to medication, rehabilitation attendance, and quality of life following acute coronary syndrome. Health Psychol. 2008;27(1):52-58 [PubMed] [Google Scholar]

58. Kronish IM, Rieckmann N, Halm EA, et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med. 2006;21(11):1178-1183 [PMC free article] [PubMed] [Google Scholar]

59. Sundel KL, Stain-Mahngren R, Andersson A, Aberg-Wistedt A, Schenck-Gustafsson K. High frequency of anxiety and angina pectoris in depressed women with coronary heart disease. Gend Med. 2007;4(2):146-156 [PubMed] [Google Scholar]

60. Amin AA, Jones AM, Nugent K, Rumsfeld JS, Spertus JA. The prevalence of unrecognized depression in patients with acute coronary syndrome. Am Heart J. 2006;152(5):928-934 [PubMed] [Google Scholar]

61. Dafer RM, Rao M, Shareef A, Sharma A. Poststroke depression. Top Stroke Rehabil. 2008;15(1):13-21 [PubMed] [Google Scholar]

62. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65(1):62-71 [PubMed] [Google Scholar]

63. Jia H, Damush TM, Qin H, et al. The impact of poststroke depression on healthcare use by veterans with acute stroke. Stroke. 2006;37(11):2796-2801 [PubMed] [Google Scholar]

64. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831-841 [PubMed] [Google Scholar]

65. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann PharmacoTher. 2002;36(7-8):1238-1248 [PubMed] [Google Scholar]

66. Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients' perspectives on medication-related problems. Patient Educ Couns. 2007;65(3):407-415 [PubMed] [Google Scholar]

67. Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553-560 [PubMed] [Google Scholar]

68. Bodenheimer T. Coordinating care: a perilous journey through the health care system. N Engl J Med. 2008;358(10):1064-1071 [PubMed] [Google Scholar]

69. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011 [PubMed] [Google Scholar]

70. Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163(1):83-90 [PubMed] [Google Scholar]

71. Roumie CL, Elasy TA, Greevy R, et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med. 2006;145(3):165-175 [PubMed] [Google Scholar]

72. Balamurugan A, Ohsfeldt R, Hughes T, Phillips M. Diabetes self-management education program for Medicaid recipients: a continuous quality improvement process. Diabetes Educ. 2006;32(6):893-900 [PubMed] [Google Scholar]

73. Praska JL, Kripalani S, Seright AL, Jacobson TA. Identifying and assisting low-literacy patients with medication use: a survey of community pharmacies. Ann PharmacoTher. 2005;39(9):1441-1445 [PubMed] [Google Scholar]

74. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion America's health literacy: why we need accessible health information. Bethesda, MD: US Dept of Health and Human Services; 2008. http://www.health.gov/communication/literacy/issuebrief/ Accessed November 15, 2010 [Google Scholar]

75. US Department of Health and Human Services. National Institutes of Health Clear communication: an NIH health literacy initiative. Bethesda, MD: National Institutes of Health; 2010. http://www.nih.gov/clearcommunication/ Accessed November 15, 2010 [Google Scholar]

76. Parikh NS, Parker RM, Nurss JR, Baker DW, Williams MV. Shame and health literacy: the unspoken connection. Patient Educ Couns. 1996;27(1):33-39 [PubMed] [Google Scholar]

77. Perez-Stable EJ, Salazar R. Issues in achieving compliance with antihypertensive treatment in the Latino population. Clin Cornerstone. 2004;6(3):49-61 [PubMed] [Google Scholar]

78. Urquhart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J. 1996;17(suppl A):8-15 [PubMed] [Google Scholar]

79. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33(6):1014-1029 [PubMed] [Google Scholar]

80. Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SS. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drugs Aging. 2008;25(10):885-892 [PubMed] [Google Scholar]

81. Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health Syst Pharm. 2009;66(16):1471-1477 [PubMed] [Google Scholar]

82. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-719 [PubMed] [Google Scholar]

83. Balu S, Simko RJ, Quimbo RM, Cziraky MJ. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence. Curr Med Res Opin. 2009;25(11):2765-2775 [PubMed] [Google Scholar]

84. Hussein MA, Chapman RH, Benner JS, et al. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study. Am J Cardiovasc Drugs. 2010;10(3):193-202 [PubMed] [Google Scholar]

85. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164(7):722-732 [PubMed] [Google Scholar]

86. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-1310 [PubMed] [Google Scholar]

87. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855-1862 [PubMed] [Google Scholar]

88. Svensson S, Kjellgren KI, Ahlner J, Säljö R. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76(2-3):157-163 [PubMed] [Google Scholar]

89. Garner JB. Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol. 2010;105(10):1495-1501 [PubMed] [Google Scholar]

90. Miller NH. Motivational interviewing as a prelude to coaching in healthcare settings. J Cardiovasc Nurs. 2010;25(3):247-251 [PubMed] [Google Scholar]

91. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55(513):305-312 [PMC free article] [PubMed] [Google Scholar]

92. Ogedegbe G, Chaplin W, Schoenthaler A, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21(10):1137-1143 [PMC free article] [PubMed] [Google Scholar]

93. Abbo ED, Zhang Q, Zelder M, Huang ES. The increasing number of clinical items addressed during the time of adult primary care visits. J Gen Intern Med. 2008;23(12):2058-2065 [PMC free article] [PubMed] [Google Scholar]

94. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Pub L No. 108-173, 117 Stat 2066

95. Pellegrino AN, Martin MT, Tilton JJ, Touchette DR. Medication therapy management services: definitions and outcomes. Drugs. 2009;69(4):393-406 [PubMed] [Google Scholar]

96. Fox D, Ried LD, Klein GE, Myers W, Foli K. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. J Am Pharm Assoc (2003). 2009;49(2):192-199 [PubMed] [Google Scholar]

97. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc (2003). 2009;49(2):164-170 [PubMed] [Google Scholar]

98. Yu AP, Yu YF, Nichol MB, Gwadry-Sridhar F. Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistence. Clin Ther. 2008;30(4):761-774, discussion 716 [PubMed] [Google Scholar]

99. Aronow HD, Novaro GM, Lauer MS, et al. In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. Arch Intern Med. 2003;163(21):2576-2582 [PubMed] [Google Scholar]

100. Fonarow GC. In-hospital initiation of statins: taking advantage of the ‘teachable moment’ [editorial]. Cleve Clin J Med. 2003;70(6):502, 504-506 [PubMed] [Google Scholar]

101. Joint Commission on Accreditation of Healthcare Organizations Using medication reconciliation to prevent errors. Sentinel Event Alert. 2006;(35):1-4 [PubMed] [Google Scholar]

Page 2